These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 340333)
1. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Behar J; Brand DL; Brown FC; Castell DO; Cohen S; Crossley RJ; Pope CE; Winans CS Gastroenterology; 1978 Feb; 74(2 Pt 2):441-8. PubMed ID: 340333 [TBL] [Abstract][Full Text] [Related]
2. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study. Petrokubi RJ; Jeffries GH Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093 [TBL] [Abstract][Full Text] [Related]
3. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial. Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391 [TBL] [Abstract][Full Text] [Related]
4. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434 [TBL] [Abstract][Full Text] [Related]
5. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670 [TBL] [Abstract][Full Text] [Related]
6. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Wesdorp E; Bartelsman J; Pape K; Dekker W; Tytgat GN Gastroenterology; 1978 May; 74(5 Pt 1):821-4. PubMed ID: 346430 [TBL] [Abstract][Full Text] [Related]
7. Cimetidine QID and BID in rapid heartburn relief and healing of lesions in gastroesophageal reflux disease. Palmer RH; Miller DM; Hedrich DA; Karlstadt RG Clin Ther; 1993; 15(6):994-1001. PubMed ID: 8111819 [TBL] [Abstract][Full Text] [Related]
8. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. McCallum RW; Ippoliti AF; Cooney C; Sturdevant RA N Engl J Med; 1977 Feb; 296(7):354-7. PubMed ID: 319356 [TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452 [TBL] [Abstract][Full Text] [Related]
10. Cimetidine vs placebo: complete gastric ulcer pain relief. Six week controlled double blind study without any antacid therapy. Collen MJ; Stubrin SE; Hánan MR; Maher JA; Rent M Acta Gastroenterol Latinoam; 1980; 10(4):291-5. PubMed ID: 7023166 [TBL] [Abstract][Full Text] [Related]
11. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux. Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725 [TBL] [Abstract][Full Text] [Related]
12. Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine. Breen KJ; Desmond PV; Whelan G Med J Aust; 1983 Nov; 2(11):555-8. PubMed ID: 6355792 [TBL] [Abstract][Full Text] [Related]
13. Endoscopic findings after antacid, cimetidine and placebo for peptic ulcer--importance of staging the lesions. Salgado JA; de Oliveira CA; Lima Júnior GF; Castro Lde P Arq Gastroenterol; 1981; 18(2):51-3. PubMed ID: 7036960 [TBL] [Abstract][Full Text] [Related]